Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-022784
Filing Date
2007-03-27
Accepted
2007-03-27 17:22:01
Documents
14
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-6037_110k.htm 10-K 1415508
2 EX-10.1 a07-6037_1ex10d1.htm EX-10.1 115322
3 EX-10.10 a07-6037_1ex10d10.htm EX-10.10 18551
4 EX-10.27 a07-6037_1ex10d27.htm EX-10.27 94245
5 EX-10.28 a07-6037_1ex10d28.htm EX-10.28 176193
6 EX-10.36 a07-6037_1ex10d36.htm EX-10.36 2502
7 EX-10.37 a07-6037_1ex10d37.htm EX-10.37 12988
8 EX-23.1 a07-6037_1ex23d1.htm EX-23.1 3590
9 EX-31.1 a07-6037_1ex31d1.htm EX-31.1 8851
10 EX-31.2 a07-6037_1ex31d2.htm EX-31.2 8862
11 EX-32.1 a07-6037_1ex32d1.htm EX-32.1 4540
12 EX-32.2 a07-6037_1ex32d2.htm EX-32.2 4573
14 GRAPHIC g60371bii001.gif GRAPHIC 5898
15 filename15.htm CORRESP 5504
  Complete submission text file 0001104659-07-022784.txt   1881096
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31812 | Film No.: 07722126
SIC: 2836 Biological Products, (No Diagnostic Substances)